TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ABUS

Arbutus Biopharma Corp

Healthcare · Biotechnology

4.90$ -0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ABUS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.55 -1.21 -1.09 -0.89 -1.23 -1.24 -0.68 -0.64 -0.23 -0.52 -0.35 -0.21
0.02 0.01 0.02 0.04 0.04 0.04 0.03 0.02 0.01 0.01 0.01 0.00
0.15 0.49 0.74 0.28 0.11 0.12 0.08 0.06 0.05 0.06 0.05 0.04
0.00 -0.36 6.14 0.56 -0.16 1.03 0.04 0.02 0.01 – – –
0.74 -0.32 -0.01 0.06 -0.08 -0.04 0.01 0.01 0.19 -0.11 -0.02 -0.05
0.05 0.05 0.08 0.13 0.02 0.01 0.00 0.01 0.00 0.01 0.00 0.00
-1.91 0.17 -1.87 0.51 -0.07 0.50 -0.20 -0.12 -0.50 0.31 0.12 0.08
0.00 0.00 0.00 0.00 0.18 0.20 0.16 0.11 – – – –
2.70 3.16 0.01 0.90 1.22 0.33 1.14 1.29 0.07 – – –
0.53 0.26 0.23 -0.22 -0.22 – – – – – – –
2.70 3.16 0.24 0.90 1.01 0.66 1.14 1.29 0.21 0.18 0.28 0.03
0.15 2.08 -2.70 0.56 -0.31 -0.09 0.27 0.54 -0.52 -0.03 0.05 -0.10
-0.60 -1.26 -1.17 -1.02 -1.25 -1.25 -0.68 -0.64 -0.24 -0.52 -0.35 -0.21

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?